Current Trials
Find out more about taking part in one of our trials
Now Recruiting
Ustekinumab in adolescents with new onset type 1 diabetes
Open to Recruitment
Trial of a new medication in 12-18 year olds with Type 1 diabetes within 100 days of diagnosis.
Interleukin-2 Therapy of Autoimmunity in Diabetes (ITAD)
Open to Recruitment
ITAD is a multicentre, randomised, double-blind, placebo-controlled clinical trial of to see if a drug called aldesleukin, can preserve insulin production in children and young adults recently diagnosed with type 1 diabetes.
CLOUD – Closed Loop from Onset in type 1 Diabetes
Recruitment closed
CLOuD is a multicentre, randomised trial of an exciting new artificial pancreas device, in newly diagnosed adolescents with type 1 diabetes (T1D) funded by the EME Programme (an MRC and NIHR partnership) and the Helmsley Charitable Trust.
Research study for people with Type 1 Diabetes: EXALT
Recruitment closed
The main purpose of this study is to assess the safety of three different doses of an investigational drug in patients who have been recently diagnosed with type 1 diabetes.
The Effect of Abatacept on the Immune System in Type 1 Diabetes
Recruitment closed
This study aims to gain a better understanding of the immune processes that lead to the destruction of insulin producing beta cells.
The Effect of Anti-IL-21 and Liraglutide in Newly Diagnosed Type 1 Diabetes
Recruitment closed
This study will investigate if a new drug Anti-IL-21 when given together with another drug marketed for type 2 diabetes called liraglutide can preserve the beta cells in subjects diagnosed with type 1 diabetes.
Join our research and help change the future of Type 1 Diabetes
Twitter Feeds
Friday update: This week we had a randomisation from @LeicResearch taking us up to 12 participants so far. 🤞for two more next week (Leeds and Swansea) and we hope to open Evelina London Children's Hospital imminently. @T1D_UK @STU_Swan